Selection and Sequencing of Available, New, and Emerging Agents for Relapsed/Refractory DLBCL

Source: New Treatment Strategies in Aggressive B-Cell Lymphomas: Advances, Application, and a Glimpse of the Future
Download Slideset
Download these slides from a live symposium to gain more insight into the selection and sequencing of therapies in relapsed/refractory DLBCL.
Jeremy S. Abramson, MD, MMSc
Format: Microsoft PowerPoint (.ppt)
File Size: 845 KB
Released: June 5, 2022

Acknowledgements

Provided by Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AbbVie
Bristol-Myers Squibb
Genmab US, Inc.
Incyte Corporation
Lilly

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings